Drawing for RX-CELL

USPTO serial 85506944

RX-CELL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
RINGLE, JAMES W
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RX-CELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Alcohol for medicinal purposes; Antiallergic medicines; Astringents for medicinal purposes; Bacteriostats for medicinal, dental and veterinary use; Bee venom for medicinal or therapeutic purposes; Breath-freshening chewing gum for medicinal purposes; Confectionery for medicinal purposes; Diagnostic reagents for medicinal use; Ginseng for medicinal use; Herb teas for medicinal purposes; Herbal teas for medicinal purposes; Herbs for medicinal purposes; Medicinal alcohol; Medicinal creams for skin care; Medicinal drinks; Medicinal hair growth preparations; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal infusions for treating acid reflux; Medicinal oils; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for treatment of cold and flu symptoms; Medicinal radix glycyrrhizae; Medicinal roots; Medicinal tea; Medicines for the treatment of gastrointestinal diseases; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Processed bee pollen for medicinal or therapeutic purposes; Processed cactus for medicinal or therapeutic purposes; Propolis for medicinal or therapeutic purposes; Radioactive substances for use in nuclear medicine; Sea water for medicinal bathing; Sugar replacement for medicinal or therapeutic purposes; Sulphonamides as medicines; Sweets for medicinal purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 25, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 25, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 24, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 29, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 24, 2012ALIEASSIGNED TO LIE
Apr 4, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2012XAECEXAMINER'S AMENDMENT ENTERED
Apr 4, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 4, 2012GNEAEXAMINERS AMENDMENT E-MAILED
Apr 4, 2012CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 4, 2012DOCKASSIGNED TO EXAMINER
Jan 7, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2012NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance